D P Merke

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia
    D P Merke
    Warren Grant Magnuson Clinical Center, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda Maryland 20892 1862, USA
    J Clin Endocrinol Metab 85:1114-20. 2000
  2. ncbi request reprint A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia
    L Laue
    Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Clin Endocrinol Metab 81:3535-9. 1996
  3. ncbi request reprint New ideas for medical treatment of congenital adrenal hyperplasia
    D P Merke
    Warren Grant Magnuson Clinical Center and the Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development of the National Institutes of Health, Bethesda, Maryland, USA
    Endocrinol Metab Clin North Am 30:121-35. 2001
  4. pmc Early androgen exposure modulates spatial cognition in congenital adrenal hyperplasia (CAH)
    S C Mueller
    MAP, NIMH, NIH, 15K North Drive, Bethesda, MD 20892, United States
    Psychoneuroendocrinology 33:973-80. 2008
  5. doi request reprint Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia
    S Verma
    the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA
    Horm Metab Res 42:607-12. 2010
  6. ncbi request reprint Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findings
    N A Avila
    Diagnostic Radiology Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892 1182, USA
    AJR Am J Roentgenol 172:1235-8. 1999
  7. ncbi request reprint Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia
    D P Merke
    Warren Grant Magnuson Clinical Center, Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA
    J Clin Endocrinol Metab 86:441-5. 2001

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia
    D P Merke
    Warren Grant Magnuson Clinical Center, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda Maryland 20892 1862, USA
    J Clin Endocrinol Metab 85:1114-20. 2000
    ..A long term study of this new regimen is ongoing...
  2. ncbi request reprint A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia
    L Laue
    Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Clin Endocrinol Metab 81:3535-9. 1996
    ..Long term studies are required to determine whether this approach can improve these children's growth and development...
  3. ncbi request reprint New ideas for medical treatment of congenital adrenal hyperplasia
    D P Merke
    Warren Grant Magnuson Clinical Center and the Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development of the National Institutes of Health, Bethesda, Maryland, USA
    Endocrinol Metab Clin North Am 30:121-35. 2001
    ..The applicability and success of these new approaches await the results of current research...
  4. pmc Early androgen exposure modulates spatial cognition in congenital adrenal hyperplasia (CAH)
    S C Mueller
    MAP, NIMH, NIH, 15K North Drive, Bethesda, MD 20892, United States
    Psychoneuroendocrinology 33:973-80. 2008
    ..Such finding suggests a pivotal role of hormonal function on brain development in humans, mirroring results from the animal literature...
  5. doi request reprint Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia
    S Verma
    the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA
    Horm Metab Res 42:607-12. 2010
    ..The degree of epinephrine deficiency in patients with CAH is associated with the severity of adrenocortical dysfunction, as well as glucocorticoid therapy...
  6. ncbi request reprint Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findings
    N A Avila
    Diagnostic Radiology Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892 1182, USA
    AJR Am J Roentgenol 172:1235-8. 1999
    ..The purpose of this study was to describe the serial sonographic findings and clinical and laboratory data obtained during follow-up of patients with congenital adrenal hyperplasia in whom testicular adrenal rest tissue develops...
  7. ncbi request reprint Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia
    D P Merke
    Warren Grant Magnuson Clinical Center, Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA
    J Clin Endocrinol Metab 86:441-5. 2001
    ..Cortef suspension has been recalled as a result of these data...